HEADER HYDROLASE/HYDROLASE INHIBITOR 17-JAN-12 4DCJ TITLE CRYSTAL STRUCTURE OF CASPASE 3, L168D MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3 SUBUNIT P17; COMPND 3 CHAIN: A, D; COMPND 4 EC: 3.4.22.56; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CASPASE-3 SUBUNIT P12; COMPND 9 CHAIN: B, E; COMPND 10 EC: 3.4.22.56; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: CASPASE INHIBITOR AC-DEVD-CHO; COMPND 14 CHAIN: C, F; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 13 MOL_ID: 3; SOURCE 14 SYNTHETIC: YES KEYWDS ALPHA/BETA HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.J.CHUNG,H.J.KANG,S.J.KIM REVDAT 1 12-DEC-12 4DCJ 0 JRNL AUTH H.J.KANG,Y.M.LEE,M.S.JEONG,M.KIM,K.H.BAE,S.J.KIM,S.J.CHUNG JRNL TITL MOLECULAR INSIGHT INTO THE ROLE OF THE LEUCINE RESIDUE ON JRNL TITL 2 THE L2 LOOP IN THE CATALYTIC ACTIVITY OF CASPASES 3 AND 7 JRNL REF BIOSCI.REP. V. 32 305 2012 JRNL REFN ISSN 0144-8463 JRNL PMID 22304005 JRNL DOI 10.1042/BSR20120009 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.11 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 60435.150 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.3 REMARK 3 NUMBER OF REFLECTIONS : 64958 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3314 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 9523 REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE : 0.2450 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 486 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3884 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 390 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.71000 REMARK 3 B22 (A**2) : -0.94000 REMARK 3 B33 (A**2) : -3.77000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -3.27000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.15 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.67 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 48.18 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ACE.PARAM REMARK 3 PARAMETER FILE 4 : ASA.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ACE.TOP REMARK 3 TOPOLOGY FILE 4 : ASA.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 4DCJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-JUN-12. REMARK 100 THE RCSB ID CODE IS RCSB070157. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-MAY-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68014 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 6000, 100MM SODIUM CITRATE PH REMARK 280 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.27650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE AC-ASP-GLU-VAL-ASP-ALDEHYDE IS PEPTIDE-LIKE, A MEMBER OF REMARK 400 INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: AC-ASP-GLU-VAL-ASP-ALDEHYDE REMARK 400 CHAIN: C, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 29 REMARK 465 GLY A 30 REMARK 465 ILE A 31 REMARK 465 SER A 32 REMARK 465 LEU A 33 REMARK 465 ASP A 175 REMARK 465 SER B 176 REMARK 465 GLY B 177 REMARK 465 VAL B 178 REMARK 465 ASP B 179 REMARK 465 ASP B 180 REMARK 465 ASP B 181 REMARK 465 MET B 182 REMARK 465 ALA B 183 REMARK 465 CYS B 184 REMARK 465 HIS B 280 REMARK 465 HIS B 281 REMARK 465 HIS B 282 REMARK 465 HIS B 283 REMARK 465 SER D 1029 REMARK 465 GLY D 1030 REMARK 465 ILE D 1031 REMARK 465 SER D 1032 REMARK 465 LEU D 1033 REMARK 465 ASP D 1175 REMARK 465 SER E 1176 REMARK 465 GLY E 1177 REMARK 465 VAL E 1178 REMARK 465 ASP E 1179 REMARK 465 ASP E 1180 REMARK 465 ASP E 1181 REMARK 465 MET E 1182 REMARK 465 ALA E 1183 REMARK 465 CYS E 1184 REMARK 465 HIS E 1278 REMARK 465 HIS E 1279 REMARK 465 HIS E 1280 REMARK 465 HIS E 1281 REMARK 465 HIS E 1282 REMARK 465 HIS E 1283 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 82 31.15 71.99 REMARK 500 ASP A 90 70.34 41.22 REMARK 500 SER A 120 -170.78 -174.25 REMARK 500 LYS B 229 -52.43 -147.10 REMARK 500 LYS D1082 31.24 73.23 REMARK 500 ASP D1090 70.64 42.08 REMARK 500 SER D1120 -173.79 -177.11 REMARK 500 LYS E1229 -55.53 -142.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF CASPASE INHIBITOR AC REMARK 800 -DEVD-CHO REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF CASPASE INHIBITOR AC REMARK 800 -DEVD-CHO REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4DCO RELATED DB: PDB REMARK 900 RELATED ID: 4DCP RELATED DB: PDB DBREF 4DCJ A 29 175 UNP P42574 CASP3_HUMAN 29 175 DBREF 4DCJ B 176 277 UNP P42574 CASP3_HUMAN 176 277 DBREF 4DCJ D 1029 1175 UNP P42574 CASP3_HUMAN 29 175 DBREF 4DCJ E 1176 1277 UNP P42574 CASP3_HUMAN 176 277 DBREF 4DCJ C 501 505 PDB 4DCJ 4DCJ 501 505 DBREF 4DCJ F 1501 1505 PDB 4DCJ 4DCJ 1501 1505 SEQADV 4DCJ ASP A 168 UNP P42574 LEU 168 ENGINEERED MUTATION SEQADV 4DCJ HIS B 278 UNP P42574 EXPRESSION TAG SEQADV 4DCJ HIS B 279 UNP P42574 EXPRESSION TAG SEQADV 4DCJ HIS B 280 UNP P42574 EXPRESSION TAG SEQADV 4DCJ HIS B 281 UNP P42574 EXPRESSION TAG SEQADV 4DCJ HIS B 282 UNP P42574 EXPRESSION TAG SEQADV 4DCJ HIS B 283 UNP P42574 EXPRESSION TAG SEQADV 4DCJ ASP D 1168 UNP P42574 LEU 168 ENGINEERED MUTATION SEQADV 4DCJ HIS E 1278 UNP P42574 EXPRESSION TAG SEQADV 4DCJ HIS E 1279 UNP P42574 EXPRESSION TAG SEQADV 4DCJ HIS E 1280 UNP P42574 EXPRESSION TAG SEQADV 4DCJ HIS E 1281 UNP P42574 EXPRESSION TAG SEQADV 4DCJ HIS E 1282 UNP P42574 EXPRESSION TAG SEQADV 4DCJ HIS E 1283 UNP P42574 EXPRESSION TAG SEQRES 1 A 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 A 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 A 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 A 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 A 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 A 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 A 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 A 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 A 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 A 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 A 147 ILE ILE GLN ALA CYS ARG GLY THR GLU ASP ASP CYS GLY SEQRES 12 A 147 ILE GLU THR ASP SEQRES 1 B 108 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 B 108 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 B 108 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 B 108 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 B 108 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 B 108 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 B 108 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 B 108 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS HIS HIS SEQRES 9 B 108 HIS HIS HIS HIS SEQRES 1 C 5 ACE ASP GLU VAL ASJ SEQRES 1 D 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 D 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 D 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 D 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 D 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 D 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 D 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 D 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 D 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 D 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 D 147 ILE ILE GLN ALA CYS ARG GLY THR GLU ASP ASP CYS GLY SEQRES 12 D 147 ILE GLU THR ASP SEQRES 1 E 108 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 E 108 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 E 108 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 E 108 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 E 108 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 E 108 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 E 108 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 E 108 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS HIS HIS SEQRES 9 E 108 HIS HIS HIS HIS SEQRES 1 F 5 ACE ASP GLU VAL ASJ HET ACE C 501 3 HET ASJ C 505 8 HET ACE F1501 3 HET ASJ F1505 8 HETNAM ACE ACETYL GROUP HETNAM ASJ (3S)-3-AMINO-4-HYDROXYBUTANOIC ACID FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 ASJ 2(C4 H9 N O3) FORMUL 7 HOH *390(H2 O) HELIX 1 1 HIS A 56 GLY A 60 5 5 HELIX 2 2 GLY A 66 LEU A 81 1 16 HELIX 3 3 THR A 92 LYS A 105 1 14 HELIX 4 4 LEU A 136 PHE A 142 1 7 HELIX 5 5 CYS A 148 THR A 152 5 5 HELIX 6 6 TRP B 214 ALA B 227 1 14 HELIX 7 7 GLU B 231 PHE B 247 1 17 HELIX 8 8 ASP B 253 HIS B 257 5 5 HELIX 9 9 GLY D 1066 LEU D 1081 1 16 HELIX 10 10 THR D 1092 LYS D 1105 1 14 HELIX 11 11 LEU D 1136 PHE D 1142 1 7 HELIX 12 12 CYS D 1148 THR D 1152 5 5 HELIX 13 13 TRP E 1214 ALA E 1227 1 14 HELIX 14 14 GLU E 1231 PHE E 1247 1 17 HELIX 15 15 ASP E 1253 HIS E 1257 5 5 SHEET 1 A12 GLU A 84 ASN A 89 0 SHEET 2 A12 GLU A 43 ASN A 51 1 N ASN A 51 O LYS A 88 SHEET 3 A12 ARG A 111 LEU A 119 1 O VAL A 117 N ILE A 48 SHEET 4 A12 LYS A 156 GLN A 161 1 O LEU A 157 N PHE A 114 SHEET 5 A12 PHE B 193 TYR B 197 1 O LEU B 194 N PHE A 158 SHEET 6 A12 CYS B 264 SER B 267 -1 O VAL B 266 N TYR B 195 SHEET 7 A12 CYS E1264 SER E1267 -1 O ILE E1265 N SER B 267 SHEET 8 A12 PHE E1193 TYR E1197 -1 N TYR E1195 O VAL E1266 SHEET 9 A12 LYS D1156 GLN D1161 1 N PHE D1158 O LEU E1194 SHEET 10 A12 ARG D1111 LEU D1119 1 N PHE D1114 O LEU D1157 SHEET 11 A12 GLU D1043 ASN D1051 1 N ILE D1048 O VAL D1117 SHEET 12 A12 GLU D1084 ASN D1089 1 O LYS D1088 N ASN D1051 SHEET 1 B 3 GLY A 122 GLU A 123 0 SHEET 2 B 3 ILE A 126 GLY A 129 -1 O ILE A 126 N GLU A 123 SHEET 3 B 3 GLY A 132 ASP A 135 -1 O GLY A 132 N GLY A 129 SHEET 1 C 2 ILE A 172 GLU A 173 0 SHEET 2 C 2 LYS E1186 ILE E1187 -1 O ILE E1187 N ILE A 172 SHEET 1 D 2 LYS B 186 ILE B 187 0 SHEET 2 D 2 ILE D1172 GLU D1173 -1 O ILE D1172 N ILE B 187 SHEET 1 E 3 GLY B 212 SER B 213 0 SHEET 2 E 3 TRP B 206 ASN B 208 -1 N ASN B 208 O GLY B 212 SHEET 3 E 3 GLU C 503 VAL C 504 -1 O GLU C 503 N ARG B 207 SHEET 1 F 3 GLY D1122 GLU D1123 0 SHEET 2 F 3 ILE D1126 GLY D1129 -1 O ILE D1126 N GLU D1123 SHEET 3 F 3 GLY D1132 ASP D1135 -1 O GLY D1132 N GLY D1129 SHEET 1 G 3 GLY E1212 SER E1213 0 SHEET 2 G 3 TRP E1206 ASN E1208 -1 N ASN E1208 O GLY E1212 SHEET 3 G 3 GLU F1503 VAL F1504 -1 O GLU F1503 N ARG E1207 LINK C ACE C 501 N ASP C 502 1555 1555 1.33 LINK C VAL C 504 N ASJ C 505 1555 1555 1.38 LINK C ACE F1501 N ASP F1502 1555 1555 1.33 LINK C VAL F1504 N ASJ F1505 1555 1555 1.39 LINK SG CYS A 163 C ASJ C 505 1555 1555 1.85 LINK SG CYS D1163 C ASJ F1505 1555 1555 1.84 SITE 1 AC1 21 SER A 63 ARG A 64 HIS A 121 GLY A 122 SITE 2 AC1 21 GLN A 161 CYS A 163 SER B 205 TRP B 206 SITE 3 AC1 21 ARG B 207 ASN B 208 SER B 209 TRP B 214 SITE 4 AC1 21 SER B 249 PHE B 250 HOH B 317 HOH C 601 SITE 5 AC1 21 HOH C 602 HOH C 603 HOH C 604 HOH C 606 SITE 6 AC1 21 HOH C 607 SITE 1 AC2 21 ARG D1064 HIS D1121 GLY D1122 GLN D1161 SITE 2 AC2 21 CYS D1163 TYR E1204 SER E1205 TRP E1206 SITE 3 AC2 21 ARG E1207 ASN E1208 SER E1209 TRP E1214 SITE 4 AC2 21 SER E1249 PHE E1250 HOH E1322 HOH F1601 SITE 5 AC2 21 HOH F1603 HOH F1604 HOH F1605 HOH F1606 SITE 6 AC2 21 HOH F1607 CRYST1 49.834 68.553 93.811 90.00 101.88 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020067 0.000000 0.004220 0.00000 SCALE2 0.000000 0.014587 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010893 0.00000